Health Care & Life Sciences » Pharmaceuticals | Daehan New Pharm Co. Ltd.

Daehan New Pharm Co. Ltd.

Daehan New Pharm Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW616
Market Cap
KRW193.79 B
Shares Outstanding
14.35 M
Public Float
8.29 M

Profile

Address
66 Jeyakgongdan 1-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.dhnp.co.kr
Updated 09/14/2018
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. It operates through the pharmaceutical and animal health product business divisions. The pharmaceutical division provides analgesics anti-inflammatory drugs and antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics and immunosuppressants, cardiovascular drugs, gatrointestinal drugs, muscle relaxants, antispasmodics, cream or ointments and others.

Financials

View All
Created with Highcharts 5.0.14Daehan New Pharm Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.1 9551 9552 6612 6614 1484 1485 6715 67120 58120 5812013201420152016201705k10k15k20k25k
Created with Highcharts 5.0.14Daehan New Pharm Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.56 70256 70271 94071 94090 23090 230109 403109 403130 816130 81620132014201520162017025k50k75k100k125k150k

Wan-Jin Lee
Chairman
Gun-Woo Bae
Co-President & Director